San Raffaele registry for adults with eosinophilic esophagitis
Prospective Registry of EoSinophilic esOphagitis (PRESO)
IRCCS San Raffaele · NCT06443346
This registry will collect clinical, endoscopic, and biopsy information from adults with eosinophilic esophagitis who are referred to the San Raffaele Motility and EoE Unit.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | IRCCS San Raffaele (other) |
| Locations | 1 site (Milan, Lombardy) |
| Trial ID | NCT06443346 on ClinicalTrials.gov |
What this trial studies
This is a prospective, observational registry enrolling adults (over 18) diagnosed with eosinophilic esophagitis and referred to the Motility and EoE Unit at IRCCS San Raffaele in Milan. Participants provide informed consent and their standard-of-care clinical, endoscopic, histologic, and related data are recorded longitudinally. No experimental treatments are administered as part of the registry; patients continue usual clinical care. The collected data will be used to describe disease features, support future retrospective or prospective studies, and foster national and international collaborations.
Who should consider this trial
Good fit: Adults (age >18) with a guideline-based diagnosis of eosinophilic esophagitis who are referred to the Motility and EoE Unit at San Raffaele and can give informed consent are ideal candidates.
Not a fit: People without a clear EoE diagnosis, those under 18, or those unwilling to provide informed consent will not be included and are unlikely to benefit from this registry.
Why it matters
Potential benefit: If successful, the registry could improve understanding of disease patterns and treatment outcomes and help design better-targeted research and care pathways for EoE patients.
How similar studies have performed: Prospective registries in EoE and other gastrointestinal diseases have been used successfully to define phenotypes, outcomes, and research priorities, so this approach is established rather than novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participant is willing and able to give informed consent for participation in the study. 2. The medical product is the standard of care for the patient or the participant is taking the medicinal product according to clinical practice 3. Being diagnosed with EoE as per guidelines of the disease Exclusion Criteria: 1. No clear diagnosis of EoE 2. Not willing to provide informed consent to the inclusion in the registry
Where this trial is running
Milan, Lombardy
- IRCCS San Raffaele — Milan, Lombardy, Italy (RECRUITING)
Study contacts
- Study coordinator: Alberto Barchi, MD
- Email: barchi.alberto@hsr.it
- Phone: 3348630784
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Eosinophilic Esophagitis